Folate and coronary heart disease
- 1 February 1998
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Lipidology
- Vol. 9 (1) , 17-22
- https://doi.org/10.1097/00041433-199802000-00005
Abstract
Low folate intake is an important determinant of elevated blood levels of homocysteine. Because elevated homocysteine has been shown to be a possible graded risk factor for CHD, sufficient folate intake may be important in the prevention of CHD. The magnitude of the association between folate and CHD is consistent with its effects on homocysteine. Curr Opin Lipidol 9:17–22. © 1998 Rapid Science LtdKeywords
This publication has 33 references indexed in Scilit:
- Folic acid fortification of the food supply. Potential benefits and risks for the elderly populationPublished by American Medical Association (AMA) ,1996
- Serum folate and risk of fatal coronary heart diseaseJAMA, 1996
- Folate and cardiovascular disease. Why we need a trial nowPublished by American Medical Association (AMA) ,1996
- A prospective study of folate and vitamin B6 and risk of myocardial infarction in US physicians.Journal of the American College of Nutrition, 1996
- Total plasma homocysteine and cardiovascular risk profile. The Hordaland Homocysteine StudyJAMA, 1995
- Plasma homocysteine and menopausal status**European Journal of Clinical Investigation, 1995
- A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductaseNature Genetics, 1995
- Folic acid and prevention of neural tube birth defects: Critical assessment of FDA proposals to increase folic acid intakesJournal of Nutrition Education, 1994
- Prevention of the First Occurrence of Neural-Tube Defects by Periconceptional Vitamin SupplementationNew England Journal of Medicine, 1992
- Prevention of neural tube defects: Results of the Medical Research Council Vitamin StudyPublished by Elsevier ,1991